Primary prevention trials
-= Not available, MI = myocardial infarction, TIA = transient ischaemic attack. * In the Women's Health Study, individual blood pressure and cholesterol levels were imputed based on categories provided by the investigators (in 10 mmHg ranges for SBP, 5 mmHg ranges for DBP and 10 mg/dL [~0.25 mmol/L] ranges for cholesterol). Continuous data are presented as mean (SD). Percentages are based on the proportions among those participants with data available. Some patients in the primary prevention trials were found, after randomisation, to have had vascular disease (i.e. prior history of myocardial infarction, cerebrovascular disease, angina pectoris, peripheral arterial disease or heart failure). 
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Web Table 3 : Rate ratios associated with risk factors for selected outcomes among people with no known vascular disease in primary prevention trials Web * The relevance of male gender can be assessed only in the two trials that included both men and women, so the confidence intervals for its relevance are wide, particularly for stroke.
GI = Gastrointestinal.
Total cholesterol was not available in the British Doctors Study.
Excluding the 2% of participants with known history of vascular disease.
Rate ratios for cholesterol are per 1mmol/L and for mean blood pressure per 20mmHg. 
Symbols and conventions as in text -figure 2
Open squares indicate trials for which only tabular data were available; these trials do not contribute to the subtotals or total. Open squares indicate trials for which only tabular data were available; these trials do not contribute to the subtotals or total. Open squares indicate trials for which only tabular data were available; these trials do not contribute to the subtotals or total.
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